Jiangsu Nhwa Pharmaceutical Co Ltd (002262) - Total Assets

Latest as of June 2026: CN¥9.54 Billion CNY ≈ $1.40 Billion USD

Based on the latest financial reports, Jiangsu Nhwa Pharmaceutical Co Ltd (002262) holds total assets worth CN¥9.54 Billion CNY (≈ $1.40 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Jiangsu Nhwa Pharmaceutical Co Ltd - Total Assets Trend (2005–2025)

This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see Jiangsu Nhwa Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Jiangsu Nhwa Pharmaceutical Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2025)

Jiangsu Nhwa Pharmaceutical Co Ltd's total assets of CN¥9.54 Billion consist of 70.1% current assets and 29.9% non-current assets. Review Jiangsu Nhwa Pharmaceutical Co Ltd debt and liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	15.7%
Accounts Receivable	CN¥1.47 Billion	16.0%
Inventory	CN¥756.78 Million	8.2%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥557.84 Million	6.1%
Goodwill	CN¥0.00	0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Jiangsu Nhwa Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 002262 stock price and chart for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jiangsu Nhwa Pharmaceutical Co Ltd's current assets represent 70.1% of total assets in 2025, an increase from 68.3% in 2005.
Cash Position: Cash and equivalents constituted 15.7% of total assets in 2025, up from 13.1% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 5.0% in 2005.
Asset Diversification: The largest asset category is accounts receivable at 16.0% of total assets.

Jiangsu Nhwa Pharmaceutical Co Ltd Competitors by Total Assets

Key competitors of Jiangsu Nhwa Pharmaceutical Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Jiangsu Nhwa Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	6.22	6.05	6.94
Quick Ratio	5.43	5.34	5.97
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥5.65 Billion	CN¥5.32 Billion	CN¥3.27 Billion

Jiangsu Nhwa Pharmaceutical Co Ltd - Advanced Valuation Insights

This section examines the relationship between Jiangsu Nhwa Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.66
Latest Market Cap to Assets Ratio	0.35
Asset Growth Rate (YoY)	9.3%
Total Assets	CN¥9.22 Billion
Market Capitalization	$3.19 Billion USD

Valuation Analysis

Below Book Valuation: The market values Jiangsu Nhwa Pharmaceutical Co Ltd's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Jiangsu Nhwa Pharmaceutical Co Ltd's assets grew by 9.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)

The table below shows the annual total assets of Jiangsu Nhwa Pharmaceutical Co Ltd from 2005 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥9.22 Billion ≈ $1.35 Billion	+9.28%
2024-12-31	CN¥8.44 Billion ≈ $1.24 Billion	+15.17%
2023-12-31	CN¥7.33 Billion ≈ $1.07 Billion	+13.07%
2022-12-31	CN¥6.48 Billion ≈ $948.40 Million	+13.76%
2021-12-31	CN¥5.70 Billion ≈ $833.68 Million	+18.39%
2020-12-31	CN¥4.81 Billion ≈ $704.17 Million	+14.53%
2019-12-31	CN¥4.20 Billion ≈ $614.81 Million	+4.18%
2018-12-31	CN¥4.03 Billion ≈ $590.13 Million	+22.15%
2017-12-31	CN¥3.30 Billion ≈ $483.12 Million	+10.98%
2016-12-31	CN¥2.97 Billion ≈ $435.32 Million	+16.62%
2015-12-31	CN¥2.55 Billion ≈ $373.28 Million	+32.68%
2014-12-31	CN¥1.92 Billion ≈ $281.35 Million	+22.75%
2013-12-31	CN¥1.57 Billion ≈ $229.20 Million	+16.47%
2012-12-31	CN¥1.34 Billion ≈ $196.79 Million	+22.97%
2011-12-31	CN¥1.09 Billion ≈ $160.03 Million	+14.60%
2010-12-31	CN¥954.30 Million ≈ $139.64 Million	+22.24%
2009-12-31	CN¥780.68 Million ≈ $114.24 Million	+7.03%
2008-12-31	CN¥729.41 Million ≈ $106.73 Million	+22.22%
2007-12-31	CN¥596.78 Million ≈ $87.33 Million	+18.34%
2006-12-31	CN¥504.30 Million ≈ $73.80 Million	+4.44%
2005-12-31	CN¥482.86 Million ≈ $70.66 Million	--

About Jiangsu Nhwa Pharmaceutical Co Ltd

SHE:002262 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.19 Billion

CN¥21.77 Billion CNY

Market Cap Rank

#4756 Global

#783 in China

Share Price

CN¥21.49

Change (1 day)

-1.10%

52-Week Range

CN¥18.23 - CN¥28.92

All Time High

CN¥31.19